Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections.

Traverse CC, Mayo-Smith LM, Poltak SR, Cooper VS.

Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):E250-9. doi: 10.1073/pnas.1207025110. Epub 2012 Dec 27.

2.

Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.

Bazzini S, Udine C, Riccardi G.

Appl Microbiol Biotechnol. 2011 Dec;92(5):887-95. doi: 10.1007/s00253-011-3616-5. Epub 2011 Oct 14. Review.

PMID:
21997606
3.

Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.

Drevinek P, Mahenthiralingam E.

Clin Microbiol Infect. 2010 Jul;16(7):821-30. doi: 10.1111/j.1469-0691.2010.03237.x. Review.

4.

Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation.

Eberl L, Tümmler B.

Int J Med Microbiol. 2004 Sep;294(2-3):123-31. Review.

PMID:
15493822
5.

Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments.

Ferreira AS, Silva IN, Oliveira VH, Cunha R, Moreira LM.

Front Cell Infect Microbiol. 2011 Dec 15;1:16. doi: 10.3389/fcimb.2011.00016. eCollection 2011. Review.

6.

Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.

Ciofu O, Mandsberg LF, Wang H, Høiby N.

FEMS Immunol Med Microbiol. 2012 Jul;65(2):215-25. doi: 10.1111/j.1574-695X.2012.00983.x. Epub 2012 Jun 1. Review. Erratum in: FEMS Immunol Med Microbiol. 2012 Oct;66(1):120.

7.

Host evasion by Burkholderia cenocepacia.

Ganesan S, Sajjan US.

Front Cell Infect Microbiol. 2012 Jan 11;1:25. doi: 10.3389/fcimb.2011.00025. eCollection 2011. Review.

8.

Pulmonary infections in patients with cystic fibrosis.

Rajan S, Saiman L.

Semin Respir Infect. 2002 Mar;17(1):47-56. Review.

PMID:
11891518
9.
10.

Pseudomonas aeruginosa biofilms in cystic fibrosis.

Høiby N, Ciofu O, Bjarnsholt T.

Future Microbiol. 2010 Nov;5(11):1663-74. doi: 10.2217/fmb.10.125. Review.

PMID:
21133688
11.

A decade of Burkholderia cenocepacia virulence determinant research.

Loutet SA, Valvano MA.

Infect Immun. 2010 Oct;78(10):4088-100. doi: 10.1128/IAI.00212-10. Epub 2010 Jul 19. Review.

13.

P. aeruginosa Biofilms in CF Infection.

Wagner VE, Iglewski BH.

Clin Rev Allergy Immunol. 2008 Dec;35(3):124-34. doi: 10.1007/s12016-008-8079-9. Review.

PMID:
18509765
14.

The clinical impact of bacterial biofilms.

Høiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PØ, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T.

Int J Oral Sci. 2011 Apr;3(2):55-65. doi: 10.4248/IJOS11026. Review.

15.

Bacterial plurality as a general mechanism driving persistence in chronic infections.

Ehrlich GD, Hu FZ, Shen K, Stoodley P, Post JC.

Clin Orthop Relat Res. 2005 Aug;(437):20-4. Review.

16.

Experimental evolution in biofilm populations.

Steenackers HP, Parijs I, Foster KR, Vanderleyden J.

FEMS Microbiol Rev. 2016 May;40(3):373-97. doi: 10.1093/femsre/fuw002. Epub 2016 Feb 18. Review.

Items per page

Supplemental Content

Write to the Help Desk